Volker A Erdmann

Title: Volker A. Erdmann: Innovator in Catalytic Nucleic Acids

Introduction

Volker A. Erdmann, located in Berlin, Germany, is an accomplished inventor with a significant contribution to the field of biotechnology. Holding five patents, Erdmann's work primarily focuses on the development of innovative systems for controlled substance release, leveraging the unique properties of catalytic nucleic acids.

Latest Patents

His latest patents include groundbreaking inventions such as the "Temperature dependent activation of catalytic nucleic acids for controlled active substance release." This invention describes an active substance release system utilizing two distinct compounds. The first compound consists of a nanoparticle combined with an oligonucleotide inhibition strand, which is hybridized with a catalytically active nucleic acid. The second compound features a carrier integrated with a substrate molecule that is coupled to a therapeutic active substance. Upon external stimulation, the catalytically active nucleic acid from the first compound is released and selectively connects with the substrate molecule of the second compound, resulting in the cleavage of the substrate and the release of the attached active substance. Another significant contribution from Erdmann is the development of novel streptavidin-binding peptides, expanding the potential applications of these specialized peptides in biotechnological research.

Career Highlights

Throughout his career, Volker A. Erdmann has collaborated with notable companies, including Grünenthal GmbH, where he leveraged his expertise to advance various biotechnological projects. His innovative approach and commitment to research have led to a successful track record of patent filings, underlining his impact in the field.

Collaborations

Erdmann has had the privilege of working alongside esteemed colleagues such as Thorsten Lamla and Jens Kurreck. These collaborations have enriched his research and fostered a dynamic exchange of ideas, contributing to the advancement of their shared objectives in science and technology.

Conclusion

In summary, Volker A. Erdmann is a notable inventor whose contributions to biotechnology, particularly in the realm of catalytic nucleic acids, continue to pave the way for significant advancements in controlled substance release systems. His innovative patents and collaborations highlight his role in the ever-evolving landscape of scientific research and innovation.